Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
BioLine RX (BLRX US)
Watchlist
9
Analysis
Health Care
•
Israel
BioLineRx Ltd. is a biopharmaceutical development company. The Company develops clinical-stage therapeutic pharmaceutical drugs.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
BioLine RX
•
03 Jun 2025 03:00
•
Issuer-paid
BLRX: First Quarter Results
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
Zacks Small Cap Research
Follow
206 Views
Share
bullish
•
BioLine RX
•
28 May 2025 22:00
•
Issuer-paid
BLRX: First Quarter Results
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
Zacks Small Cap Research
Follow
192 Views
Share
bullish
•
BioLine RX
•
03 Apr 2025 23:00
•
Issuer-paid
BLRX: 2024 Financial Results
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
Zacks Small Cap Research
Follow
181 Views
Share
bullish
•
BioLine RX
•
19 Feb 2025 23:00
•
Issuer-paid
BLRX: Aphexda Transition Progressing
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
Zacks Small Cap Research
Follow
310 Views
Share
bullish
•
BioLine RX
•
04 Dec 2024 06:00
•
Issuer-paid
BLRX: Ayrmid Assumes Commercialization Efforts
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
Zacks Small Cap Research
Follow
393 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.6
x